Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04527445 · ClinicalTrials.gov registry record · NA

Fluoroscopy Radiation Reduction During Sacral Neuromodulation Lead Placement

A NA study of Overactive Bladder and Urge Incontinence, sponsored by Loma Linda University.

Recruiting
Registry status
NA
Development phase
44
Enrollment target
1
Study location

NCT04527445 is a NA study of Overactive Bladder and Urge Incontinence that is actively recruiting participants, run by Loma Linda University. The registered enrollment target is 44 participants, below the 211-participant average among 45 other Overactive Bladder trials with a reported enrollment target (79% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04527445, a NA study of Overactive Bladder and Urge Incontinence, is actively recruiting participants, sponsored by Loma Linda University.

RECRUITING
Registry status
NA
Development phase
44 participants
Enrollment target
1
Study location

Study Summary

Fluoroscopy is performed when placing a lead during a sacral neuromodulation procedure. During lead placement, subjects will receive either conventional or experimental fluoroscopic settings. The radiation exposure will be compared between the two groups.

Interventions

  • PROCEDURE Reduced radiation fluoroscopy
  • PROCEDURE Conventional fluoroscopy

Study Locations (1)

California

  • Loma Linda University Health - Loma Linda

Trial Details

FieldValue
Enrollment Target 44 participants
Start Date 2026-06
Est. Completion 2027-06
Phase NA

Sponsor

Loma Linda University

237 total trials

What the Registry Record Tells You About NCT04527445

The ClinicalTrials.gov registry entry for NCT04527445 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 44 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 211-participant average among 45 other Overactive Bladder trials with a reported enrollment target (79% lower). The listed sponsor is Loma Linda University, which has 237 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with Overactive Bladder appearing as the primary indexed condition, and to 2 interventions - of which Reduced radiation fluoroscopy is the first listed.

NCT04527445 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT04527445 about?

NCT04527445 is a clinical study titled "Fluoroscopy Radiation Reduction During Sacral Neuromodulation Lead Placement". Fluoroscopy is performed when placing a lead during a sacral neuromodulation procedure. During lead placement, subjects will receive either conventional or experimental fluoroscopic settings. The radiation exposure will be compared between the two groups.

What is the current status of trial NCT04527445?

This trial is currently recruiting. It is a NA study. The enrollment target is 44 participants. The study started on 2026-06. Estimated completion is 2027-06.

What conditions does trial NCT04527445 study?

This clinical trial studies the following conditions: Overactive Bladder, Urge Incontinence, Radiation Exposure, Urgency-frequency Syndrome.

What interventions are being tested in trial NCT04527445?

The interventions under investigation include: Reduced radiation fluoroscopy (PROCEDURE), Conventional fluoroscopy (PROCEDURE).

Who is sponsoring clinical trial NCT04527445?

This trial is sponsored by Loma Linda University, which has 237 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04527445 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Overactive Bladder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.